Caleb Pharmaceuticals, Inc. is an R&D and manufacturing-based pharmaceutical company that specializes in controlled-release drug delivery technology research and pharmaceutical / consumer patches production. Over the years, Caleb has successfully applied the se-of -the-art proprietary technologies and innovative spirit to develop and manufacture a variety of products for medical and consumer applications. Our company commits to the highest standards of manufacturing and quality assurance by being in compliance with current Good Manufacturing Practices (cGMP) to improve all human's health and quality of life.
| Website | https://www.caleb-pharm.com/en/ |
| Revenue | $5 million |
| Employees | 5 (1 on RocketReach) |
| Phone | +886 3 212 9300 |
| Technologies |
JavaScript
,
HTML
,
Font Awesome
+3 more
(view full list)
|
| Industry | Pharmaceutical Manufacturing, Manufacturing General, Manufacturing |
| Keywords | Drug Delivery, Innovative Drug Delivery, Controlled Release, Advanced Drug Delivery, Transdermal Patches, Drug Development, Pharmaceutical Research, R&D Pharmaceutical, Drug Manufacturing, Pharmaceutical Manufacturing, Consumer Health, Topical Drug Delivery, Extended Release, Delivery Systems, Pharmaceutical Production |
| Competitors | Teva Pharmaceuticals USA, Inc., Mylan Belgium, Sandoz, Rising Pharmaceuticals, Lupin Limited, Amgen, Aurobindo Pharma LTD, SUN PHARMA, Cipla, Boehringer Ingelheim +42 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies |
Looking for a particular Caleb Pharmaceuticals employee's phone or email?
The Caleb Pharmaceuticals annual revenue was $5 million in 2026.
1 people are employed at Caleb Pharmaceuticals.
The NAICS codes for Caleb Pharmaceuticals are [325, 3254, 32541, 32].
The SIC codes for Caleb Pharmaceuticals are [283, 28].